Literature DB >> 11818485

Ischemic stroke therapy.

C Stapf1, J P Mohr.   

Abstract

Stroke is the most common life-threatening neurologic disease and the leading cause of serious long-term disability. The advent of new treatment options for selected patients suffering ischemic stroke (such as systemic administration of tissue plasminogen activator or catheter-guided intra-arterial thrombolysis), the structural reorganization of patient care facilities into stroke units, and interdisciplinary cerebrovascular centers have broadened the scope of possible therapeutic interventions in the acute and post-acute phase after cerebral ischemia. This review summarizes currently available and recommended treatment modalities for acute ischemic stroke from an interdisciplinary perspective, including medical, neurointerventional, and neurosurgical therapies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11818485     DOI: 10.1146/annurev.med.53.082901.104106

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  25 in total

Review 1.  Angiogenesis-regulating microRNAs and Ischemic Stroke.

Authors:  Ke-Jie Yin; Milton Hamblin; Y Eugene Chen
Journal:  Curr Vasc Pharmacol       Date:  2015       Impact factor: 2.719

2.  Correlation of optical attenuation coefficient estimated using optical coherence tomography with changes in astrocytes and neurons in a chronic photothrombosis stroke model.

Authors:  Shanshan Yang; Kezhou Liu; Lin Yao; Kaiyuan Liu; Guoqing Weng; Kedi Xu; Peng Li
Journal:  Biomed Opt Express       Date:  2019-11-14       Impact factor: 3.732

3.  Ca(2+) signaling in astrocytes and its role in ischemic stroke.

Authors:  Shinghua Ding
Journal:  Adv Neurobiol       Date:  2014

Review 4.  Krüpple-like factors in the central nervous system: novel mediators in stroke.

Authors:  Ke-Jie Yin; Milton Hamblin; Yanbo Fan; Jifeng Zhang; Y Eugene Chen
Journal:  Metab Brain Dis       Date:  2013-12-15       Impact factor: 3.584

5.  VGF, Which Is Induced Transcriptionally in Stroke Brain, Enhances Neurite Extension and Confers Protection Against Ischemia In Vitro.

Authors:  Muneki Sakamoto; Yuta Miyazaki; Keiko Kitajo; Atsushi Yamaguchi
Journal:  Transl Stroke Res       Date:  2015-04-29       Impact factor: 6.829

6.  miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia.

Authors:  Ke-Jie Yin; Zhen Deng; Huarong Huang; Milton Hamblin; Changqing Xie; Jifeng Zhang; Y Eugene Chen
Journal:  Neurobiol Dis       Date:  2010-01-04       Impact factor: 5.996

7.  Photothrombosis ischemia stimulates a sustained astrocytic Ca2+ signaling in vivo.

Authors:  Shinghua Ding; Tiannan Wang; Wenju Cui; Philip G Haydon
Journal:  Glia       Date:  2009-05       Impact factor: 7.452

8.  Altered long non-coding RNA transcriptomic profiles in brain microvascular endothelium after cerebral ischemia.

Authors:  J Zhang; L Yuan; X Zhang; M H Hamblin; T Zhu; F Meng; Y Li; Y E Chen; K J Yin
Journal:  Exp Neurol       Date:  2015-12-31       Impact factor: 5.330

Review 9.  Window of opportunity: estrogen as a treatment for ischemic stroke.

Authors:  Ran Liu; Shao-Hua Yang
Journal:  Brain Res       Date:  2013-01-20       Impact factor: 3.252

10.  Neutrophil protein kinase Cdelta as a mediator of stroke-reperfusion injury.

Authors:  Wen-Hai Chou; Doo-Sup Choi; Hong Zhang; Dezhi Mu; Tom McMahon; Viktor N Kharazia; Clifford A Lowell; Donna M Ferriero; Robert O Messing
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.